HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Can Temper Public Perception Of Risk By Lending Context

This article was originally published in The Rose Sheet

Executive Summary

A greater part of the personal-care industry's public relations campaign should be encouraging consumers to put risks into context, according to strategist Dan McGinn, CEO of the McGinn Group

You may also be interested in...



Industry Must Unite To Preserve Consumer Faith – New Council Chair Brestle

The personal-care industry needs to speak "with one voice" in order to strengthen consumer confidence in the safety of its products, Personal Care Products Council Chairman Dan Brestle urged at the trade association's annual meeting in Boca Raton, Fla

Profound Beauty Grows Virtual Presence To Avoid Going Mass

"Personalized" hair-care firm Profound Beauty is growing its presence online to attract new customers while preserving its status as a prestige brand

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015290

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel